Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/18670883

Download in:

View as

General Info

PMID
18670883